Agree 100% on your first point.
Agree partly on your second point; that any potential Vax deal definitely to be funded,100%, by 3rd party, upfront funds to Admedus a ‘super’ outcome, percentage of future royalties (likely to be limited) almost a ‘given’ as part of the deal.
That a ‘ ... bounty from products which might eventuate from AI products ... ‘ is a reality that it that far in the future that it has no relevance, sorry to say that.
Future of Admedus should be 100% solely focused, imo, on the Adapt IP, this will possibly, in years to come, be a company that is vastly different from the ‘beast’ it was pre Code Red era.
This is pretty corny but imagine this company transforming from a larvae to a caterpillar to a butterfly .... lol, make note to myself, don’t drink Wild Turkey and post!
- Forums
- ASX - By Stock
- Does the vax deal matter?
Agree 100% on your first point. Agree partly on your second...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M |
Open | High | Low | Value | Volume |
$15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 312 | $15.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.65 | 626 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 312 | 15.510 |
1 | 650 | 15.500 |
1 | 646 | 15.490 |
1 | 6 | 15.450 |
1 | 50 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.880 | 250 | 1 |
16.000 | 134 | 1 |
16.200 | 200 | 1 |
16.250 | 1000 | 1 |
16.500 | 1034 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |